Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

AGA linked to worse COVID-19 outcomes in men.

Testosterone's effects on COVID-19 are unclear and need more research.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Long COVID patients have more health issues than non-infected people.

COVID-19 can cause skin problems directly or from using protective gear and sanitizers, and knowing this can help treat patients better.

Insulin resistance linked to obesity may increase COVID-19 severity.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

AGA might indicate higher risk for severe COVID-19.

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Mothers with lower stress during pregnancy but higher stress after birth had infants with lower development scores.

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.